EP Patent

EP2641602A1 — Method for treating gynecological diseases

Assigned to Preglem SA · Expires 2013-09-25 · 13y expired

What this patent protects

The present invention relates generally to a combination for use in the treatment of gynaecological diseases and associated disabling symptoms thereof, in a subject in need thereof, said pharmaceutical combination for use comprising co-administering a suitable pharmaceutical comp…

USPTO Abstract

The present invention relates generally to a combination for use in the treatment of gynaecological diseases and associated disabling symptoms thereof, in a subject in need thereof, said pharmaceutical combination for use comprising co-administering a suitable pharmaceutical composition for oral administration comprising a first progesterone receptor modulator and a pharmaceutical composition suitable for vaginal and/ or intrauterine administration comprising a second progesterone receptor modulator.

Drugs covered by this patent

Patent Metadata

Patent number
EP2641602A1
Jurisdiction
EP
Classification
—
Expires
2013-09-25
Drug substance claim
No
Drug product claim
No
Assignee
Preglem SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.